Diabetes, Vol 44, Issue 12 1369-1374, Copyright © 1995 by American Diabetes Association

ARTICLES

Pancreatic islet GLUT2 glucose transporter mRNA and protein expression in humans with and without NIDDM

J Ferrer, C Benito and R Gomis
Endocrinology and Nutrition Service, University of Barcelona School of Medicine, Hospital Clinic, Spain.

GLUT2 glucose transporter mRNA has been shown to be underexpressed in pancreatic islets of numerous animal models of non-insulin-dependent diabetes mellitus (NIDDM). It has been proposed that this molecular defect contributes to the pathogenesis of diabetes, although information concerning the expression of GLUT2 in human pancreatic islet tissue is lacking. In contrast to the high abundance of GLUT2 in rat islets, human islets were found to express distinctly low levels of this glucose transporter mRNA and protein. Thus, a sensitive competitive reverse transcription-polymerase chain reaction assay was developed to quantify human GLUT2 mRNA. We obtained pancreases from 4 human organ donors with previously diagnosed NIDDM and 11 nondiabetic donors and found no significant differences in GLUT2 mRNA between the two groups. GLUT2 mRNA was 0.24 +/- 0.08 amol/micrograms RNA (mean +/- SE) in pancreases from humans with diabetes and 0.27 +/- 0.06 amol/microgram RNA in those without this diagnosis. Similarly, human pancreatic islet GLUT2 protein was measured by immunoblot and found to be present at similar levels in two individuals with diabetes relative to six control samples. These results thus demonstrate the existence of species differences in the abundance of islet GLUT2 mRNA and protein. Furthermore, the analysis of islet GLUT2 in a small sample of human organ donors with and without diabetes raises the possibility that decreased beta-cell GLUT2 may not represent a widespread feature of humans with NIDDM.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L Zhao, Z Li, M Kullin, L A H Borg, and F A Karlsson Alterations in net glucose uptake and in the pancreatic B-cell GLUT2 transporter induced by diazoxide and by secretory stimuli J. Endocrinol., May 1, 2005; 185(2): 291 - 299. [Abstract] [Full Text] [PDF]

				K. H. Moley, M. M.-Y. Chi, and M. M. Mueckler Maternal hyperglycemia alters glucose transport and utilization in mouse preimplantation embryos Am J Physiol Endocrinol Metab, July 1, 1998; 275(1): E38 - E47. [Abstract] [Full Text] [PDF]

				B. Antoine, A.-M. Lefrancois-Martinez, G. Le Guillou, A. Leturque, A. Vandewalle, and A. Kahn Role of the GLUT 2 Glucose Transporter in the Response of the L-type Pyruvate Kinase Gene to Glucose in Liver-derived Cells J. Biol. Chem., July 18, 1997; 272(29): 17937 - 17943. [Abstract] [Full Text] [PDF]

				B. Thorens, M.-T. Guillam, F. Beermann, R. Burcelin, and M. Jaquet Transgenic Reexpression of GLUT1 or GLUT2 in Pancreatic beta Cells Rescues GLUT2-null Mice from Early Death and Restores Normal Glucose-stimulated Insulin Secretion J. Biol. Chem., July 28, 2000; 275(31): 23751 - 23758. [Abstract] [Full Text] [PDF]